Stockscreener 앱 받기
9.71
0.31%
0.03
시간 외 거래:
9.65
-0.06
-0.62%
Immatics N V 주식(IMTX)의 최신 뉴스
Immatics NV (IMTX) seeing strong enrollment in a key phase 3 trial of drug candidate - MSN
Immatics (IMTX) Expected to Announce Earnings on Thursday - MarketBeat
Immatics (IMTX) Chief Development Officer files Form 3 detailing equity - Stock Titan
Immatics (IMTX) CMO Cedrik Britten reports option, RSU and share holdings - Stock Titan
Immatics General Counsel reports option and RSU holdings | IMTX SEC FilingForm 3 - Stock Titan
[Form 3] Immatics N.V. Initial Statement of Beneficial Ownership - Stock Titan
Immatics (IMTX) CEO reports options, RSUs and share holdings - Stock Titan
Immatics (IMTX) director reports sizeable stock option holdings - Stock Titan
Immatics (IMTX) CFO reports 350,000 stock options holding - Stock Titan
Immatics N.V. (IMTX) director Eliot Forster details stock option holdings - Stock Titan
Immatics (IMTX) Chief People Officer reports 211,000 share options on Form 3 - Stock Titan
Immatics (IMTX) director discloses existing stock option grants - Stock Titan
Immatics (IMTX) director discloses multiple long-dated stock options - Stock Titan
Immatics (IMTX) director reports multiple long-dated stock option grants - Stock Titan
Immatics (IMTX) COO details stock options, RSUs and share holdings - Stock Titan
Immatics (IMTX) CBO details stock option and RSU positions - Stock Titan
Immatics (IMTX) director Chambre details ordinary share and option stakes - Stock Titan
Immatics (IMTX) director Michael G. Atieh reports stock option positions - Stock Titan
Immatics (IMTX) Chief Innovation Officer discloses option and RSU stakes - Stock Titan
Immatics (IMTX) director entities disclose indirect share and option stakes - Stock Titan
Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX) - MSN
Aug PreEarnings: What is the target price for Immatics NV stockWeekly Trading Summary & Verified Technical Signals - baoquankhu1.vn
Risk Check: Is Immatics NV a defensive stock2026 Winners & Losers & Reliable Momentum Entry Alerts - baoquankhu1.vn
Immatics NV Stock (ISIN: NL0015255052) Advances on Promising TCR-T Therapy Data Amid Biotech Sector - AD HOC NEWS
Why Immatics (IMTX) Is Down 6.4% After Deepening Losses And Highlighting SUPRAME Phase 3 Progress - simplywall.st
Immatics N.V. (IMTX) director Hothum discloses options and indirect shares - Stock Titan
IMTX: Jefferies Analyst Biren Amin Rates Immatics with a "Buy" and Sets Price Target at $18.00 | IMTX Stock News - GuruFocus
Immatics (NASDAQ:IMTX) Stock Price Up 9.3%Here's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Immatics Phase 3 Progress Sharpens View On Anzu Cel Launch Upside - Yahoo Finance
Immatics N.V. $IMTX Shares Purchased by Baker BROS. Advisors LP - MarketBeat
Immatics NV Stock (ISIN: NL0015255052) Holds Steady Amid Biotech Sector Volatility - AD HOC NEWS
(IMTX) Risk Channels and Responsive Allocation - Stock Traders Daily
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate - Insider Monkey
Can Immatics NV Equity Warrant generate free cash flow2026 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Shares Gap DownTime to Sell? - MarketBeat
Is Immatics’ 2025 Loss and PRAME Pipeline Push Altering The Investment Case For Immatics (IMTX)? - simplywall.st
Jefferies Financial Group Inc. Takes $10.18 Million Position in Immatics N.V. $IMTX - MarketBeat
Insider Buy: What is the target price for Immatics NV stockDay Trade & Real-Time Volume Triggers - baoquankhu1.vn
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX) - Seeking Alpha
Immatics NV earnings beat by €0.13, revenue topped estimates - Investing.com Nigeria
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to "Hold" - MarketBeat
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to “Hold” - Defense World
Is Immatics N.V. Equity Warrant stock near bottom after declineGold Moves & Low Risk Growth Stock Ideas - Naître et grandir
Tech Rally: Should I invest in Immatics NV Equity Warrant before earnings2025 Momentum Check & Short-Term Swing Trade Alerts - baoquankhu1.vn
Immatics 2025 Financial Results: Q4 Revenue $23M, Annual Loss $222.2MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Immatics (NASDAQ:IMTX) Announces Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Immatics Earnings Report: Q4 Overview - Sahm
Immatics Announces Full Year 2025 Financial Results and Business Update - Investing News Network
Immatics: Fourth Quarter Financial Overview - Bitget
Immatics: Q4 Earnings Snapshot - KVUE
Immatics (IMTX) Projects Promising Developments for 2026 After R - GuruFocus
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance - TipRanks
Immatics (NASDAQ: IMTX) 2025 results show revenue drop and larger net loss - Stock Titan
Immatics N.V Gross Profit | IMTX - MLQ.ai
immatics biotechnologies GmbH (IMTXW) Competitors - Meyka
(IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Immatics (NASDAQ:IMTX) Lowered to “Sell” Rating by Wall Street Zen - Defense World
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
1.20%
0.06%
자본화:
|
볼륨(24시간):